Medacta announced successful completion of the first Reverse Shoulder Arthroplasty (RSA) surgeries utilizing its NextAR™ Shoulder, the first CE-marked and FDA-cleared Augmented Reality surgical application with intraoperative guidance for total shoulder replacement.
NextAR Shoulder is designed to improve efficiency and precision in total shoulder replacement, while supporting the advancement of personalized surgery.
Prior to surgery, the surgeon uses a 3D virtual model of the patient’s shoulder to choose the best implant and position to restore the patient’s unique anatomy. NextAR Shoulder enhances the preoperative implant-bone preparation with unique intraoperative orientation assessments, allowing surgeons to track real-time positioning.
During the operation, the surgeon uses the NextAR Smart Glasses to visualize surgical actions and information in real-time, directly on the operative field. This ensures that all adjustments are based on real-time data and enables the surgeon to remain focused on the patient for an optimal user experience. With this process, the NextAR Shoulder platform allows for exceptional precision and control, ultimately translating to enhanced efficiency in the operating room.
NextAR is the first platform to offer Augmented Reality solutions for both joint replacement and spine procedures. In line with Medacta’s philosophy of healthcare sustainability, a single hardware with limited capital investment and low per-case disposable cost will be able to host diverse software, with additional economic benefits for the healthcare systems.
The NextAR surgical platform is part of Medacta’s MySolutions ecosystem. Together with a comprehensive portfolio of implants and surgical techniques, MySolutions empowers Medacta’s holistic approach to personalized medicine, aiming to bring value to every step of the patient journey from preoperative through postoperative care.
Source: Medacta
Medacta announced successful completion of the first Reverse Shoulder Arthroplasty (RSA) surgeries utilizing its NextAR™ Shoulder, the first CE-marked and FDA-cleared Augmented Reality surgical application with intraoperative guidance for total shoulder replacement.
NextAR Shoulder is designed to improve efficiency and precision in total...
Medacta announced successful completion of the first Reverse Shoulder Arthroplasty (RSA) surgeries utilizing its NextAR™ Shoulder, the first CE-marked and FDA-cleared Augmented Reality surgical application with intraoperative guidance for total shoulder replacement.
NextAR Shoulder is designed to improve efficiency and precision in total shoulder replacement, while supporting the advancement of personalized surgery.
Prior to surgery, the surgeon uses a 3D virtual model of the patient’s shoulder to choose the best implant and position to restore the patient’s unique anatomy. NextAR Shoulder enhances the preoperative implant-bone preparation with unique intraoperative orientation assessments, allowing surgeons to track real-time positioning.
During the operation, the surgeon uses the NextAR Smart Glasses to visualize surgical actions and information in real-time, directly on the operative field. This ensures that all adjustments are based on real-time data and enables the surgeon to remain focused on the patient for an optimal user experience. With this process, the NextAR Shoulder platform allows for exceptional precision and control, ultimately translating to enhanced efficiency in the operating room.
NextAR is the first platform to offer Augmented Reality solutions for both joint replacement and spine procedures. In line with Medacta’s philosophy of healthcare sustainability, a single hardware with limited capital investment and low per-case disposable cost will be able to host diverse software, with additional economic benefits for the healthcare systems.
The NextAR surgical platform is part of Medacta’s MySolutions ecosystem. Together with a comprehensive portfolio of implants and surgical techniques, MySolutions empowers Medacta’s holistic approach to personalized medicine, aiming to bring value to every step of the patient journey from preoperative through postoperative care.
Source: Medacta
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.